Condor Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,963
| Closed | -$230K | – | 197 |
|
|
2023
Q3 | $230K | Buy |
3,963
+113
| +3% | +$6.92K | 0.03% | 155 |
|
|
2023
Q2 | $246K | Buy |
+3,850
| New | +$258K | 0.03% | 156 |
|
|
2023
Q1 | – | Sell |
-4,318
| Closed | -$311K | – | 208 |
|
|
2022
Q4 | $311K | Buy |
4,318
+58
| +1% | +$4.37K | 0.04% | 172 |
|
|
2022
Q3 | $303K | Sell |
4,260
-29,475
| -87% | -$2.14M | 0.04% | 171 |
|
|
2022
Q2 | $2.6M | Sell |
33,735
-159
| -0.5% | -$12.1K | 0.34% | 65 |
|
|
2022
Q1 | $2.48M | Buy |
33,894
+1,409
| +4% | +$94.6K | 0.28% | 88 |
|
|
2021
Q4 | $2.02M | Sell |
32,485
-21,904
| -40% | -$1.28M | 0.22% | 97 |
|
|
2021
Q3 | $3.22M | Sell |
54,389
-799
| -1% | -$52.6K | 0.34% | 74 |
|
|
2021
Q2 | $3.69M | Buy |
55,188
+149
| +0.3% | +$9.72K | 0.41% | 60 |
|
|
2021
Q1 | $3.48M | Buy |
55,039
+93
| +0.2% | +$5.79K | 0.41% | 61 |
|
|
2020
Q4 | $3.41M | Buy |
54,946
+355
| +0.7% | +$21.8K | 0.43% | 61 |
|
|
2020
Q3 | $3.29M | Buy |
54,591
+7,172
| +15% | +$432K | 0.48% | 58 |
|
|
2020
Q2 | $2.79M | Buy |
47,419
+555
| +1% | +$33.2K | 0.43% | 64 |
|
|
2020
Q1 | $2.61M | Buy |
46,864
+8,300
| +22% | +$507K | 0.48% | 56 |
|
|
2019
Q4 | $2.48M | Buy |
38,564
+9,656
| +33% | +$553K | 0.36% | 70 |
|
|
2019
Q3 | $1.47M | Sell |
28,908
-1,198
| -4% | -$56.3K | 0.23% | 103 |
|
|
2019
Q2 | $1.36M | Buy |
30,106
+75
| +0.2% | +$3.49K | 0.21% | 112 |
|
|
2019
Q1 | $1.43M | Sell |
30,031
-57
| -0.2% | -$2.84K | 0.23% | 104 |
|
|
2018
Q4 | $1.56M | Sell |
30,088
-300
| -1% | -$16.1K | 0.29% | 91 |
|
|
2018
Q3 | $1.89M | Hold |
30,388
| – | – | 0.34% | 76 |
|
|
2018
Q2 | $1.68M | Buy |
30,388
+500
| +2% | +$27K | 0.32% | 82 |
|
|
2018
Q1 | $1.89M | Sell |
29,888
-480
| -2% | -$30.9K | 0.41% | 68 |
|
|
2017
Q4 | $1.86M | Buy |
30,368
+480
| +2% | +$30K | 0.38% | 69 |
|
|
2017
Q3 | $1.91M | Hold |
29,888
| – | – | 0.38% | 65 |
|
|
2017
Q2 | $1.67M | Buy |
29,888
+604
| +2% | +$32.9K | 0.35% | 71 |
|
|
2017
Q1 | $1.59M | Sell |
29,284
-165
| -0.6% | -$9.05K | 0.34% | 72 |
|
|
2016
Q4 | $1.72M | Buy |
29,449
+15
| +0.1% | +$820 | 0.38% | 62 |
|
|
2016
Q3 | $1.59M | Hold |
29,434
| – | – | 0.37% | 70 |
|
|
2016
Q2 | $2.17M | Hold |
29,434
| – | – | 0.52% | 49 |
|
|
2016
Q1 | $1.88M | Hold |
29,434
| – | – | 0.46% | 56 |
|
|
2015
Q4 | $2.02M | Sell |
29,434
-165
| -0.6% | -$10.9K | 0.5% | 52 |
|
|
2015
Q3 | $1.75M | Sell |
29,599
-100
| -0.3% | -$6.34K | 0.46% | 55 |
|
|
2015
Q2 | $1.98M | Hold |
29,699
| – | – | 0.47% | 58 |
|
|
2015
Q1 | $1.92M | Buy |
+29,699
| New | +$1.86M | 0.45% | 60 |
|
Other funds holding BMY
Condor Capital Management's BMY Position: Q4 2023 in Review
Condor Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,963 shares — an estimated $230K sold.
Condor Capital Management first reported a position in BMY in Q1 2015 and held it in 34 quarters. The position peaked at $3.69M in Q2 2021. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Condor Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Condor Capital Management sold 3,963 Bristol-Myers Squibb shares in Q4 2023, an estimated $230K.
- Condor Capital Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 34 quarters.
- Condor Capital Management's Bristol-Myers Squibb position peaked at $3.69M in Q2 2021.
- 2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Condor Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.